Issue 8, 2017

Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease

Abstract

The kidney is one of the body's main filtration organs, and hence, opportunity exists for designing nanomedicine that can naturally accumulate in the kidneys for renal diseases. In addition to traditional physiochemical properties for kidney accumulation, such as size and charge, synthesized nanoparticles can be conjugated with targeting ligands which further home the nanocarriers to cell types of interest. In this review, we highlight key studies that have shown success in utilizing peptide- or antibody-based ligands in nanoparticles to target the glomerulus, podocytes, or renal tubule cells in the kidney. In addition, other ligand candidates which have shown renal affinity, but have not yet been integrated into a nanoparticle are also presented. These studies can provide insight into the design of novel clinical solutions for improved detection, prevention, and treatment of renal diseases using nanomedicine efforts.

Graphical abstract: Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease

Article information

Article type
Minireview
Submitted
28 Mar 2017
Accepted
02 May 2017
First published
04 May 2017

Biomater. Sci., 2017,5, 1450-1459

Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease

J. Wang, J. J. Masehi-Lano and E. J. Chung, Biomater. Sci., 2017, 5, 1450 DOI: 10.1039/C7BM00271H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements